| Dr Marilyn Jo Rogers, MD | |
|
975 E 3rd St, Chattanooga, TN 37403-2103 | |
| (423) 778-7296 | |
| (423) 778-8068 |
| Full Name | Dr Marilyn Jo Rogers |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 975 E 3rd St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518907690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 10019 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marilyn Jo Rogers, MD 105 Riverpoint Rd, Signal Mountain, TN 37377-2237 Ph: (423) 886-5986 | Dr Marilyn Jo Rogers, MD 975 E 3rd St, Chattanooga, TN 37403-2103 Ph: (423) 778-7296 |
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the company's submission of a biologic license application for belatacept, which is in ongoing phase III development for use in kidney transplantation.
An esteemed military surgeon, who helps treat some of the world's most complex battlefield injuries, will present at Arab Health's first ever Trauma and Acute Care Surgery Conference.
Compugen Ltd. (NASDAQ: CGEN) announced today results demonstrating the therapeutic potential of CGEN-15022, a Compugen-discovered B7/CD28-like membrane protein, as an immune checkpoint target for treatment of multiple cancers.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma and refractory advanced colorectal cancer.
Researchers at the University of Pittsburgh have identified how a single aberrant cell can duplicate to form cancerous tumors, suggesting a specific protein mechanism as a target for the treatment of cancer, they report in a paper titled "Spindle Multipolarity Is Prevented by Centrosomal Clustering," published in the Jan. 7 issue of Science.
› Verified 2 days ago
Joseph Kerby Gray, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 2525 De Sales Ave, Chattanooga, TN 37404 Phone: 423-495-2525 | |
Ronald A. Gracy Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 941 Spring Creek Rd, Chattanooga, TN 37412 Phone: 423-894-7870 Fax: 865-539-8008 | |
Dr. Jocelyn May De Guzman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1755 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-680-8534 | |
Dr. Jeffrey Durant Clinkscales, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7628 | |
Dr. Shelley L Murphy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1018 Blackford Street, Chattanooga, TN 37403 Phone: 423-778-7000 | |
Samuel Wilson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-697-0014 Fax: 423-648-6280 | |
Dr. James B Bardoner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7296 Fax: 423-778-8086 |